Enzymatic Therapy
Artery Advantage
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
5
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
6 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Vitamin B6 UNII · KV2JZ1BI6Z | 20 mg | 1000% |
| Folate UNII · 935E97BOY8 | 800 mcg | 200% |
| Vitamin B12 UNII · 8406EY2OQA | 400 mcg | 6667% |
| Garlinase 5000 Garlic Blend Garlic | 320 mg | — |
| Pomegranate Fruit Extract Pomegranate | 50 mg | — |
| Vitamin K2 Vitamin K (menaquinone)UNII · 71ANL51TLA | 45 mcg | — |
Flagged excipients
1 flagged · authority citations
- ● AVOIDTitanium Dioxide colorcolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
FDA CAERS · adverse event context
5
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Cellulose · Rice Dextrin · modified Cellulose Gum · Modified Cellulose · Silicon Dioxide · Magnesium Stearate · Sodium Alginate · Ammonium Hydroxide · fractionated Coconut Oil · Oleic Acid · Stearic Acid